AMF siRNA treatment of keloid through inhibition signaling pathway of RhoA/ROCK1

In conclusion, AMF siRNA is expected to be a novel strategy to treat KD by inhibiting signaling pathway of RhoA/ROCK1.
Source: Genes and Diseases - Category: Genetics & Stem Cells Source Type: research